The price of this share is at 1,53$, Spero Therapeutics Inc, with address at 675 MASSACHUSETTS AVENUE 14TH FLOOR, CAMBRIDGE, Massachusetts, 2139, United States, is a publicly traded company and its visible heads at the moment are Angela Talley (Vice President-Clinical Development), Ankit A. Mahadevia (President, Chief Executive Officer & Director), Cristina Larkin (Chief Operating Officer), David Melnick (Chief Medical Officer), Satyavrat Shukla (Treasurer, Chief Financial & Accounting Officer), Thomas R. Parr (Chief Scientific Officer), Troy Lister (Senior Vice President-Research & Development). Focused on Biotechnology: Pharmaceutical Preparations was created long ago in United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 1,49$ moving between 1,43$ and 1,56$, it is a notable difference that allows quick purchases and sales.
Their latest annual data shows an income of desconocido.
The last registered opening is of desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
